PharmAthene IncAdd to My Watchlist

PIP:USNYSE MKT LLCIndustry: Medical-Biomedical/Gene
  • 1.62
    Last
  • 0.00  0.00%
    Today's Change
  • 1.62
    Previous Close
  • Today
     
    0.98
    2.05
    52 Week Low - High
8:04 pm ET 5/23/2013
Intraday data is at least 15 minutes delayed; All prices are in the local currency; Time is ET.
Stock Price Details
Shares Outstanding49 million
Market Cap$80 million
Return on Equity ttm-36.70%
Last DividendPIP:US does not pay a dividend
Earnings
EPS: Year Actual ttm-0.100
EPS: Year Est. 12/13 ttm-0.025
 
EPS: Quarterly Actual 3/13 -0.03
EPS: Quarterly Est. 6/13 -0.06
 
Price/Earnings ttm--
Relative Price/Earnings--
Earnings Growth Rate-25.00
Company Description
PharmAthene, Inc. develops biological and chemical defense products. The Company's services include expertise in infectious diseases and genome science across the spectrum to pharmaceutical marketing and management.
Revenue$25 million
Net Income$-5 million
Total Assets$23 million
Employees57
Web Sitewww.pharmathene.com

Latest Headlines

No news available.

    Watchlist

    Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.

    Sign In Now

     

    Not Registered?

    Get complete access to The Washington Post online - it's FREE!